Resistin-like molecule β is abundantly expressed in foam cells and is involved in atherosclerosis development

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 8, 2013, Pages 1986-1993

  Kushiyama, Akifumi ^a   Sakoda, Hideyuki ^b   Oue, Naohide ^d   Okubo, Masamichi ^e   Nakatsu, Yusuke ^e   Ono, Haruya ^e   Fukushima, Toshiaki ^e   Kamata, Hideaki ^b   Nishimura, Fusanori ^e   Kikuchi, Takako ^a   Fujishiro, Midori ^b   Nishiyama, Koichi ^b   Aburatani, Hiroyuki ^c   Kushiyama, Sakura ^a   Iizuka, Masaki ^f   Taki, Naoyuki ^f   Encinas, Jeffrey ^f   Sentani, Kazuhiro ^d   Ogonuki, Narumi ^g   Ogura, Atsuo ^g   Kawazu, Shoji ^b   Yasui, Wataru ^d   Higashi, Yukihito ^e   Kurihara, Hiroki ^e   Katagiri, Hideki ^h   Asano, Tomoichiro ^e   more..

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^g RIKEN BIORESOURCE CENTER   (Japan)

^h TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Inflammation; Macrophage

Indexed keywords

APOLIPOPROTEIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; RESISTIN LIKE MOLECULE BETA; SCAVENGER RECEPTOR; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; FOAM CELL; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA TYPE 3; IN VITRO STUDY; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ATHEROSCLEROSIS; INFLAMMATION; MACROPHAGE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11C; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL LINE; FATTY ACIDS; FEMALE; FOAM CELLS; HORMONES, ECTOPIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; PRIMARY CELL CULTURE; VASCULITIS;

EID: 84881023724     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301546     Document Type: Article

References (32)

1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature. 2001;409: 307-312.
2. Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, Cho YM, Park YJ, Kim SY, Lee HK, Park KS. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004;89: 150-156.
3. Takeishi Y, Niizeki T, Arimoto T, Nozaki N, Hirono O, Nitobe J, Watanabe T, Takabatake N, Kubota I. Serum resistin is associated with high risk in patients with congestive heart failure-a novel link between metabolic signals and heart failure. Circ J. 2007;71: 460-464.
4. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111: 932-939.
5. Hu WL, Qiao SB, Hou Q, Yuan JS. Plasma resistin is increased in patients with unstable angina. Chin Med J (Engl). 2007;120: 871-875.
6. Pesce JT, Ramalingam TR, Wilson MS, Mentink-Kane MM, Thompson RW, Cheever AW, Urban JF Jr, Wynn TA. Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog. 2009;5:e1000393.
7. Wang ML, Shin ME, Knight PA, Artis D, Silberg DG, Suh E, Wu GD. Regulation of RELM/FIZZ isoform expression by Cdx2 in response to innate and adaptive immune stimulation in the intestine. Am J Physiol Gastrointest Liver Physiol. 2005;288:G1074-G1083.
8. Chumakov AM, Kubota T, Walter S, Koeffler HP. Identification of murine and human XCP1 genes as C/EBP-epsilon-dependent members of FIZZ/ Resistin gene family. Oncogene. 2004;23: 3414-3425.
9. Shojima N, Ogihara T, Inukai K, Fujishiro M, Sakoda H, Kushiyama A, Katagiri H, Anai M, Ono H, Fukushima Y, Horike N, Viana AY, Uchijima Y, Kurihara H, Asano T. Serum concentrations of resistin-like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow. Diabetologia. 2005;48: 984-992.
10. Kushiyama A, Shojima N, Ogihara T, et al. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J Biol Chem. 2005;280: 42016-42025.
11. Renigunta A, Hild C, Rose F, Klepetko W, Grimminger F, Seeger W, Hänze J. Human RELMbeta is a mitogenic factor in lung cells and induced in hypoxia. FEBS Lett. 2006;580: 900-903.
12. He W, Wang ML, Jiang HQ, Steppan CM, Shin ME, Thurnheer MC, Cebra JJ, Lazar MA, Wu GD. Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology. 2003;125: 1388-1397.
13. Fujio J, Kushiyama A, Sakoda H, Fujishiro M, Ogihara T, Fukushima Y, Anai M, Horike N, Kamata H, Uchijima Y, Kurihara H, Asano T. Regulation of gut-derived resistin-like molecule beta expression by nutrients. Diabetes Res Clin Pract. 2008;79: 2-10.
14. Herbert DR, Yang JQ, Hogan SP, Groschwitz K, Khodoun M, Munitz A, Orekov T, Perkins C, Wang Q, Brombacher F, Urban JF Jr, Rothenberg ME, Finkelman FD. Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med. 2009;206: 2947-2957.
15. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, Wu GD. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137:1716-24.e1.
16. Nair MG, Guild KJ, Du Y, Zaph C, Yancopoulos GD, Valenzuela DM, Murphy A, Stevens S, Karow M, Artis D. Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection- induced intestinal inflammation. J Immunol. 2008;181: 4709-4715.
17. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003;111: 225-230.
18. Krimi RB, Letteron P, Chedid P, Nazaret C, Ducroc R, Marie JC. Resistinlike molecule-beta inhibits SGLT-1 activity and enhances GLUT2- dependent jejunal glucose transport. Diabetes. 2009;58: 2032-2038.
19. Ogonuki N, Inoue K, Hirose M, Miura I, Mochida K, Sato T, Mise N, Mekada K, Yoshiki A, Abe K, Kurihara H, Wakana S, Ogura A. A highspeed congenic strategy using first-wave male germ cells. PLoS One. 2009;4:e4943.
20. Hogan SP, Seidu L, Blanchard C, Groschwitz K, Mishra A, Karow ML, Ahrens R, Artis D, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rothenberg ME. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol. 2006;118: 257-268.
21. Artis D, Wang ML, Keilbaugh SA, He W, Brenes M, Swain GP, Knight PA, Donaldson DD, Lazar MA, Miller HR, Schad GA, Scott P, Wu GD. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci U S A. 2004;101: 13596-13600.
22. Fang C, Meng Q, Wu H, Eid G, Zhang G, Zhang X, Yang S, Huang K, Lee TH, Corrigan CJ, Ying S. Resistin-like molecule-beta is a human airway remodelling mediator. Eur Respir J. 2012;39: 458-466.
23. Angelini DJ, Su Q, Yamaji-Kegan K, Fan C, Teng X, Hassoun PM, Yang SC, Champion HC, Tuder RM, Johns RA. Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension. Am J Respir Cell Mol Biol. 2009;41: 553-561.
24. Groeneweg M, Kanters E, Vergouwe MN, Duerink H, Kraal G, Hofker MH, de Winther MP. Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL. J Lipid Res. 2006;47: 2259-2267.
25. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290:F625-F631.
26. Ferreira V, van Dijk KW, Groen AK, Vos RM, van der Kaa J, Gijbels MJ, Havekes LM, Pannekoek H. Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation. Atherosclerosis. 2007;192: 283-290.
27. Hansson GK, Robertson AK, Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006;1: 297-329.
28. Zhao B, Song J, Chow WN, St Clair RW, Rudel LL, Ghosh S. Macrophagespecific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice. J Clin Invest. 2007;117: 2983-2992.
29. McVay LD, Keilbaugh SA, Wong TM, Kierstein S, Shin ME, Lehrke M, Lefterova MI, Shifflett DE, Barnes SL, Cominelli F, Cohn SM, Hecht G, Lazar MA, Haczku A, Wu GD. Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest. 2006;116: 2914-2923.
30. Cho HJ, Shashkin P, Gleissner CA, Dunson D, Jain N, Lee JK, Miller Y, Ley K. Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol Genomics. 2007;29: 149-160.
31. Butcher MJ, Herre M, Ley K, Galkina E. Flow cytometry analysis of immune cells within murine aortas. J Vis Exp. 2011;53:e2828.
32. Oh J, Riek AE, Weng S, Petty M, Kim D, Colonna M, Cella M, Bernal- Mizrachi C. Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation. J Biol Chem. 2012;287: 11629-11641.